Alban Bessede
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
GABA promotes resistance to immunotherapy in patients with TLS-positive tumors.
Journal: Cancer cell
Published: July 10, 2025
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 25, 2024
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 25, 2024
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside.
Journal: Med (New York, N.Y.)
Published: September 30, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab.
Journal: Signal transduction and targeted therapy
Published: August 01, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas.
Journal: Journal of hematology & oncology
Published: July 26, 2024
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
Journal: Molecular cancer
Published: July 19, 2024
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures.
Journal: Cell reports. Medicine
Published: July 09, 2024
Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors.
Journal: Oncoimmunology
Published: July 03, 2024
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response.
Journal: Cell reports. Medicine
Published: April 18, 2024
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis.
Journal: Nature cancer
Published: April 04, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.
Journal: Molecular cancer
Published: January 15, 2024
Last Updated: 09/26/2026